Home / Resources / White Paper / Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

February 3, 2021 White Paper

By: Piet van der Graaf

Contact Us

By: Dr. Piet van der Graaf, SVP

About the author

By: Piet van der Graaf

Recommended for you

Why Medical/Regulatory Writing Services Use Style Guides & Lexicons

eChalk Talk: Avoid getting “lost in translation” – Increase confidence in translational research using biosimulation

On-Demand Webinar

PBPK Modeling to Support Bioequivalence & Generic Product Approvals

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers